GSA Capital Partners’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-28,665
Closed -$1.54M – 2010
2026
Q2
$1.54M Buy
28,665
+14,854
+108% +$657K 0.1% 268
2026
Q1
$666K Buy
+13,811
New +$945K 0.04% 739
2025
Q4
– Sell
-9,886
Closed -$277K – 1822
2025
Q3
$277K Buy
+9,886
New +$197K 0.02% 1247
2024
Q4
– Sell
-30,464
Closed -$1.34M – 1755
2024
Q3
$1.34M Buy
+30,464
New +$1.18M 0.1% 297

Other funds holding GPCR

GSA Capital Partners's GPCR Position: Q3 2026 in Review

GSA Capital Partners sold out of Structure Therapeutics (GPCR) in Q3 2026, closing a stake of 28,665 shares — an estimated $1.54M sold.

GSA Capital Partners first reported a position in GPCR in Q3 2024 and held it in 4 quarters. The position peaked at $1.54M in Q2 2026. 169 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • GSA Capital Partners reported no remaining Structure Therapeutics position as of Q3 2026 after selling out during the quarter.
  • GSA Capital Partners sold 28,665 Structure Therapeutics shares in Q3 2026, an estimated $1.54M.
  • GSA Capital Partners first reported a position in Structure Therapeutics in Q3 2024 and held it in 4 quarters.
  • GSA Capital Partners's Structure Therapeutics position peaked at $1.54M in Q2 2026.
  • 169 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.